The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Editorial

The Role of the Primary Care Physician in the Prevention, Diagnosis and Treatment of Breast Cancer: Contemporary Knowledge and Controversies

Authors: Albert S. Braverman, MD

Abstract

Dr. Mary Hooks reminds us that we have achieved the primary prevention of breast cancer (BC) without seeming to have noticed it.1 The specific estrogen receptor modulators tamoxifen and raloxifene have both been shown to significantly reduce the risk of BC in pre- and postmenopausal American women; the latter without an increased risk of endometrial cancer. Yet few without a history of BC are receiving these agents. Patients and physicians have conflated tamoxifen with nonspecific cytotoxic drugs and have avoided it. But raloxifene is already used to retard osteoporosis. It is time for primary care physicians to prescribe it for women at increased risk, assuming the same responsibility for primary BC prevention as they already do for secondary prevention by mammographic screening.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Hooks MA. Breast cancer: risk assessment and prevention. South Med J 2010;103:333–338.
 
2. Morrow M, Harris JR. More mastectomies: is this what patients really want? J Clin Oncol 2009;27:4038–4040.
 
3. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in woman with newly diagnosed breast cancer: systematic review and meta-analysis. J Clin Oncol 2009;27:5640–5649.
 
4. National Institutes of Health Consensus Development Conference Statement: Breast cancer screening for women ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997;89:1015–1026.
 
5. Ernster VL. Mammography screening for women aged 40 through 49—a guidelines saga and clarion call for informed decision making. Am J Public Health 1997;87:1103–1106.
 
6. Wells J. Mammography and the politics of randomized controlled trials. BMJ 1998;317:1224–1230.
 
7. Braverman AS. The public stake in physician authority. Pharos Alpha Omega Alpha Honor Med Soc 1998;61:32–35.